Clinical practice: Today's understanding of the haemolytic uraemic syndrome

European Journal of Pediatrics

Volumn 169, Issue 1, 2010, Pages 7-13

  Scheiring, Johanna ^a   Rosales, Alejandra ^a   Zimmerhackl, Lothar Bernd ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Acute renal failure; Complement; Dialysis; EHEC; Factor H; Streptococci; Transplantation

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; COMPLEMENT COMPONENT C5; COMPLEMENT FACTOR H; COMPLEMENT FACTOR I; COMPLEMENT MEMBRANE ATTACK COMPLEX; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ECULIZUMAB; ELECTROLYTE; FIBRINOLYTIC AGENT; FRESH FROZEN PLASMA; GLOBOTRIAOSYLCERAMIDE; HEMOGLOBIN; HEPARIN; IMMUNOGLOBULIN; LACTATE DEHYDROGENASE; MEMBRANE COFACTOR PROTEIN; STEROID;

ACUTE KIDNEY FAILURE; ANTIHYPERTENSIVE THERAPY; CELL DAMAGE; CLINICAL FEATURE; CLINICAL PRACTICE; COMPLEMENT ALTERNATIVE PATHWAY; CREATININE BLOOD LEVEL; DIARRHEA; DISEASE ASSOCIATION; DRUG MECHANISM; ENDOTHELIUM CELL; ERYTHROCYTE TRANSFUSION; ESCHERICHIA COLI INFECTION; FLUID RESUSCITATION; GENE MUTATION; HEMOGLOBIN BLOOD LEVEL; HEMOLYTIC ANEMIA; HEMOLYTIC UREMIC SYNDROME; HUMAN; KIDNEY TRANSPLANTATION; LACTATE DEHYDROGENASE BLOOD LEVEL; MOLECULAR MECHANICS; MORBIDITY; MORTALITY; NEPHRECTOMY; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PATIENT MONITORING; PLASMAPHERESIS; PNEUMOCOCCAL INFECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEIN CLEAVAGE; REMISSION; RENAL REPLACEMENT THERAPY; REVIEW; SHIGA TOXIN PRODUCING ESCHERICHIA COLI; SHIGELLA; STREPTOCOCCUS PNEUMONIAE; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT OUTCOME;

CHILD; COMPLEMENT SYSTEM PROTEINS; HEMOLYTIC-UREMIC SYNDROME; HUMANS; KIDNEY FAILURE, ACUTE; PROGNOSIS; RENAL REPLACEMENT THERAPY;

EID: 71449117854     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00431-009-1039-4     Document Type: Review

References (44)

1. CK Ahn E Klein PI Tarr 2008 Isolation of patients acutely infected with Escherichia coli O157:H7: low-tech, highly effective prevention of hemolytic uremic syndrome Clin Infect Dis 46 8 1197 1199 10.1086/587664 18444855 (Pubitemid 351589902)
2. G Ariceta N Besbas S Johnson, et al. 2009 The European Paediatric Study Group for HUS. Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome Pediatr Nephrol 24 4 687 696 10.1007/s00467-008-0964-1 18800230
3. ML Barilla-LaBarca MK Liszewski JD Lambris, et al. 2002 Role of membrane Cofactor protein (CD46) in regulation of C4b and C3b deposits on cells J Immunol 168 12 6298 6304 1:CAS:528:DC%2BD38XksFWmtb0%3D 12055245
4. TG Boyce DL Swerdlow PM Griffin 1995 Escherichia coli O157:H7 and the hemolytic uremic syndrome N Engl J Med 333 364 10.1056/NEJM199508103330608 1:STN:280:DyaK2MzjsVSnug%3D%3D 7609755
5. J Brandt C Wong S Mihm, et al. 2002 Invasive pneumococcal disease and hemolytic uremic syndrome Pediatrics 110 371 375 10.1542/peds.110.2.371 12165593 (Pubitemid 34833025)
6. GR Cabrera JD Fortenberry BL Warshaw, et al. 1998 Hemolytic uremic syndrome associated with invasive Streptococcus pneumoniae infection Pediatrics 101 699 703 10.1542/peds.101.4.699 1:STN:280:DyaK1c7ptVWgsQ%3D%3D 9521959 (Pubitemid 28180160)
7. JB Cochran VM Panzarino LY Maes FW Tecklenburg 2004 Pneumococcus-induced T-antigen activation in hemolytic uremic syndrome Pediatr Nephrol 19 317 321 10.1007/s00467-003-1382-z 14714171 (Pubitemid 38313017)
8. RS de Cordoba JE de Goicoechea 2008 Translational mini-review series on complement factor H: genetics and disease associations of human complement factor H Clin Exp Immunol 151 1 13 18081690
9. MA Dragon-Durey V Fremeaux-Bacchi 2005 Atypical haemolytic uraemic syndrome and mutations in complement regulator genes Springer Semin Immunopathol 27 359 374 10.1007/s00281-005-0003-2 1:CAS:528:DC%2BD2MXht1SqtLfO 16189652 (Pubitemid 41639887)
10. V Fremeaux-Bacchi MA Dragon-Durey J Blouin, et al. 2004 Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome J Med Genet 41 e84 10.1136/jmg.2004.019083 1:STN:280:DC%2BD2czgvFyjug%3D%3D 15173250
11. V Frémeaux-Bacchi EC Miller MK Liszewski, et al. 2008 Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome Blood 112 13 4948 4952 10.1182/blood-2008-01-133702 18796626
12. C Gasser E Gautier A Steck, et al. 1955 Hämolytisch-urämische Syndrome: bilaterale Nierenrindennekrose bei akut erworbenen hämolytischen Anämien Schweiz Med Wochenschr 85 905 909 1:STN:280:DyaG28%2Fis1SntA%3D%3D 13274004
13. A Gerber AH Kirchhoff-Modapour S Obieglo, et al. 2003 Successful (?) therapy of hemolytic uremic syndrome with factor H abnormality Pediatr Nephrol 18 952 955 10.1007/s00467-003-1192-3 12836093 (Pubitemid 37121633)
14. Habib R (1992) Pathology of the hemolytic uremic syndrome. In: Kaplan B, Trompeter R, Moake J (eds) Hemolytic uremic syndrome and thrombotic thrombocytopenic purpura. Marcel dekker, New York, pp 315-353
15. MA Karmali M Petric C Lim, et al. 1985 The association between idiopathic haemolytic uraemic syndrome and infection by Verotoxin producing E. coli J Infect Dis 151 775 782 1:STN:280:DyaL2M7osVSrtg%3D%3D 3886804
16. D Kavanagh THJ Goodship A Richars 2006 Atypical haemolytic uraemic syndrome Br Med Bull 77-78 5 22 10.1093/bmb/ldl004 16968692 (Pubitemid 46092270)
17. D Kavanagh EJ Kemp E Mayland, et al. 2005 Mutations in complement factor I predispose to development of atypical haemolytic uraemic syndrome J Am Soc Nephrol 16 2150 2155 10.1681/ASN.2005010103 1:CAS:528:DC%2BD2MXms1egsL4%3D 15917334 (Pubitemid 41716447)
18. J Liu M Hutzler C Li I Pechet 2001 Thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS). The new thinking J Thromb Thrombolysis 3 261 272 10.1023/A:1011921122595 (Pubitemid 33072073)
19. C Loirat P Niaudet 2003 The risk of recurrence after haemolytic uraemic syndrome after renal transplantation in children Pediatr Nephrol 18 1095 1101 10.1007/s00467-003-1289-8 13680331 (Pubitemid 37406854)
20. NE Moghal MA Ferreira AH Howie, et al. 1998 The late histologic findings in diarrhoea associated haemolytic uraemic syndrome J Pediatr 133 220 223 10.1016/S0022-3476(98)70223-9 1:STN:280:DyaK1cznsFCnsg%3D%3D 9709709
21. J Mukherjee K Chios D Fishwild, et al. 2002 Human Stx2 specific monoclonal antibodies prevent systemic complications of Escherichia coli O157:H7 infection Infect Immun 70 612 619 10.1128/IAI.70.2.612-619.2002 1:CAS:528:DC%2BD38XoslOrtw%3D%3D 11796590 (Pubitemid 34083820)
22. S Nathanson G Deschenes 2001 Prognosis of Streptococcus pneumoniae induced hemolytic uremic syndrome Pediatr Nephrol 16 362 365 10.1007/s004670100564 1:STN:280:DC%2BD3M3lsFegsA%3D%3D 11354782 (Pubitemid 32366672)
23. M Noris G Remuzzi 2005 Haemolytic uraemic syndrome J Am Soc Nephrol 16 1035 1050 10.1681/ASN.2004100861 1:CAS:528:DC%2BD2MXjsVGgu7o%3D 15728781 (Pubitemid 41710314)
24. M Noris G Remuzzi 2008 Translational mini-review series on complement factor H: therapies of renal diseases associated with complement factor H abnormalities: atypical haemolytic uraemic syndrome and membranoproliferative glomerulonephritis Clin Exp Immunol 151 2 199 209 1:CAS:528:DC%2BD1cXitVWntL8%3D 18070148 (review)
25. J Nuernberger O Witzke AO Saez, et al. 2009 Eculizumab for atypical hemolytic uremic syndrome N Engl J Med 360 5 542 544 10.1056/NEJMc0808527 1:CAS:528:DC%2BD1MXht1aitbY%3D
26. D Orth K Grif LB Zimmerhackl R Würzner 2008 Prevention and treatment of enterohemorrhagic Escherichia coli infections in humans Expert Rev Anti Infect Ther 6 1 101 108 10.1586/14787210.6.1.101 1:CAS:528:DC%2BD1cXhslejs74%3D 18251667 Review
27. F Proulz JM Liet D Michele, et al. 2000 Hemolytic uremic syndrome associated with invasive Streptococcus infection Pediatrics 105 462 463 10.1542/peds.105.2.462
28. F Prüfer J Scheiring S Sautter, et al. 2006 Terminal complement complex (C5b-9) in children with recurrent haemolytic uraemic syndrome Semin Thromb Hemost 32 2 121 127 10.1055/s-2006-939768 16575687
29. A Richards EJ Kemp MK Liszewski, et al. 2003 Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome Proc Natl Acad Sci USA 100 22 12966 12971 10.1073/pnas.2135497100 1:CAS:528:DC%2BD3sXoslKmsrs%3D 14566051 (Pubitemid 37340009)
30. P Ruggenenti M Noris G Remuzzi 2001 Thrombotic microangiopathy, hemolytic uremic syndrome and thrombocytopenic purpura Kidney Int 60 2001 831 846 10.1046/j.1523-1755.2001.060003831.x 1:CAS:528:DC%2BD3MXmvFKjtrY%3D 11532079 (Pubitemid 34205784)
31. P Ruggenenti G Remuzzi 1998 Pathophysiology and management of thrombotic microangiopathies J Nephrol 11 6 300 310 1:STN:280:DyaK1M7ls1answ%3D%3D 10048496
32. J Scheiring SP Andreoli LB Zimmerhackl 2008 Treatment and outcome of Shiga-toxin-associated hemolytic uremic syndrome Pediatr Nephrol 23 1749 1760 10.1007/s00467-008-0935-6 18704506
33. AS Sheoran S Chapman-Bonofiglio BR Harvey, et al. 2005 Human antibody against Shiga toxin 2 administered to piglets after the onset of diarrhea due to Escherichia coli O157:H7 prevents fatal systemic complications Infect Immun 73 4607 4613 10.1128/IAI.73.8.4607-4613.2005 1:CAS:528:DC%2BD2MXmvVCjtbs%3D 16040972 (Pubitemid 41105615)
34. J Slavicek Z Puretic M Novak V Sarnavka 1995 The role of plasma exchange in the treatment of severe forms of hemolytic uremic syndrome in childhood Artif Organs 19 506 10.1111/j.1525-1594.1995.tb02370.x 1:STN:280:DyaK287ivV2rsg%3D%3D 8526789
35. PI Tarr CA Gordon WL Chandler 2005 Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome Lancet 365 9464 1073 1086 1:CAS:528: DC%2BD2MXisFGrs7Y%3D 15781103
36. M Van Dyck W Proesmans 2004 Renoprotection by ACE inhibitors after severe hemolytic uremic syndrome Pediatr Nephrol 19 6 688 690 10.1007/s00467-004-1451- y 15064939 (Pubitemid 38771745)
37. HM Verweyen H Karch F Allerberger LB Zimmerhackl 1999 Enterohemorrhagic Escherichia coli (EHEC) in pediatric hemolytic uremic syndrome: a prospective study in Germany and Austria Infection 27 6 341 347 10.1007/s150100050040 1:STN:280:DC%2BD3c%2FovFOhsg%3D%3D 10624594
38. HM Verweyen H Karch M Brandis LB Zimmerhackl 2000 Enterohemorrhagic Escherichia coli infection: following transmission routes Pediatr Nephrol 14 73 83 10.1007/s004670050018 1:STN:280:DC%2BD3c7hvFygsQ%3D%3D 10654337
39. LB Zimmerhackl 2000 E. coli, antibiotics and the hemolytic uremic syndrome N Engl J Med 342 26 1930 1936 10.1056/NEJM200006293422611
40. LB Zimmerhackl N Besbas T Jungraithmayr, et al. 2006 European Study Group for haemolytic uraemic syndromes and related disorders: epidemiology, clinical presentation, and pathophysiology of atypical and recurrent hemolytic uremic syndrome Semin Thromb Hemost 32 2 113 120 10.1055/s-2006-939767 16575686
41. LB Zimmerhackl J Scheiring F Pruefer, et al. 2007 Renal transplantation in HUS patients with disorders of complement regulation Pediatr Nephrol 22 1 10 16 10.1007/s00467-006-0210-7 17058051 (Pubitemid 46138353)
42. Zimmerhackl LB, Verweyen HM, Gerber A, et al. (2002) Das hämolytisch urämische Syndrom. Deutsches Ärzteblatt, Ausgabe 4 vom 25.01.2002, Seite A-196/B-157/C-153
43. P Zipfel 2001 Haemolytic uraemic syndrome: how do factor H mutants mediate endothelial damage? Trends Immunol 22 345 348 10.1016/S1471-4906(01) 01972-X 1:CAS:528:DC%2BD3MXks1Oktrw%3D 11429311 (Pubitemid 32673632)
44. PF Zipfel S Heinen M Jozsi C Skerka 2006 Complement and diseases: defective alternative pathway control results in kidney and eye diseases Mol Immunol 43 97 106 10.1016/j.molimm.2005.06.015 1:CAS:528:DC%2BD2MXms1Ogu7Y%3D 16026839 (Pubitemid 41021526)